Knee replacement patients may get better pain relief from a continuous nerve block, study suggests
NCT ID NCT07581886
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two methods of pain control after total knee replacement: a single injection of numbing medicine versus a continuous drip through a small tube for 48 hours. About 78 adults aged 40-80 will be randomly assigned to one of the two groups. The goal is to see which approach provides better pain relief and recovery, with careful checks to ensure the tube stays in the right place.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 78 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 40-80 yrs * Scheduled for unilateral total knee arthroplatsy * ASA I-III * BMI 18-35 kg/㎡ * Able to read and understand consent form Exclusion Criteria: * Allergy to local anesthetics * Infection at the block site * History of neuropathy or peripheral nerve disease * Coagulation disorders or use of anticoagulants (if discontinuation is not possible) * Communication disorders or cognitive impairment * Chronic opioid use (≥30 MME/day, 3 months or more) * Severe chronic pain (NRS ≥7/10, 3 months or more) * Renal impairment (eGFR \<30 mL/min/1.73m²) * Hepatic impairment (Child-Pugh C) * Blood coagulation disorders * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthroplasty are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which knee implant lasts longer? trial pits two designs against each other
- Can your own cells ease osteoarthritis pain?
- Can your own bone marrow beat steroids for knee pain?
- Can a new shoulder implant restore Pain-Free movement?
- Which nerve block keeps you moving after knee surgery?
- Ultrasound may predict which patients get poor pain relief from a common knee block